Investigators will present four studies
highlighting collaborations across ORIEN, Aster Insights,
NIH
TAMPA,
Fla., May 21, 2024 /PRNewswire/ -- Aster
Insights, the leading provider of scientific and clinical
intelligence for oncology discovery, today announced the company
and members of the Oncology Research Information Exchange
Network® (ORIEN) will be presenting at the American
Society of Clinical Oncology (ASCO) annual meeting, which will be
held May 31 – June 4, in Chicago,
IL. Four abstracts examining melanoma, kidney,
gastrointestinal, and uterine cancers highlight the work of
collaborators across ORIEN, Aster Insights, and the National
Institutes of Health (NIH) with several authors contributing to
more than one of these studies, demonstrating the importance of
cross-functional, multidisciplinary research.
"The abstracts chosen for presentation at ASCO highlight the
unique and diverse investigations that can be launched when premier
cancer institutions are collaborating and harnessing deep
multimodal data," said Dr. Anand
Shah, CEO of Aster Insights. "Robust representation across
cancer types and patient demographics enables us to launch research
that yields critical insights to better care for patients."
Schedule of Aster Insights' ASCO Poster Presentations:
- Riya Patel. Genomic
signature analysis and survival outcomes in cholangiocarcinoma
(CCA) using oncology research information exchange network (ORIEN)
database.
Abstract 4101; Poster 81
- Ahmad Tarhini. A
prognostic model based on selected cell state and cellular
community scores in patients with advanced melanoma treated with
immune checkpoint inhibitors (Ecotype-ICI score) as a predictor of
ICI immunotherapeutic benefits.
Abstract 9568; Poster
352
- Juan Antonio Raygoza Garay.
Unraveling the gene expression signatures with associated
clinical outcomes in papillary renal cell
carcinoma.
Abstract 4558; Poster 253
- Taylor Rives. Comparison
of the clinical and genomic profiles of endometrial cancer in
Appalachian and non-Appalachian patients.
Abstract 5591;
Poster 462
"We look forward to sharing our important work to construct an
immune cell state atlas through ecotype analyses to foster a deeper
understanding of the correlations between immune cell states and
responsiveness to immune checkpoint inhibitors," said Ahmad Tarhini, MD, PhD of Moffit Cancer Center
and Chair of the ORIEN Scientific Committee and ORIEN
Immuno-Oncology Research Interest Group. "This collaborative effort
draws on multidisciplinary expertise and rich clinicogenomic data
from across ORIEN and Aster Insights, as well as the NIH."
Aster Insights will be attending ASCO. Please contact us to
request a meeting.
About Aster Insights
Aster Insights is the leading provider of scientific and
clinical intelligence for oncology discovery. We partner with drug,
biologics, diagnostics, and medical device developers to accelerate
oncology product discovery and development. Aster Insights leads
the Oncology Research Information Exchange Network® (ORIEN), a
consortium of the nation's leading cancer centers that conduct
Total Cancer Care®, the world's largest and longest running
observational research study in oncology. Together, we are changing
the way cancer is studied, treated, and prevented. Learn more at
www.AsterInsights.com and follow us on LinkedIn and
Twitter.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aster-insights-orien-to-present-research-abstracts-at-the-60th-asco-annual-meeting-302151676.html
SOURCE Aster Insights